Department of Neurology, University of Cologne, Germany.
Department of Neurology, University of Cologne, Germany; Department of Epileptology, University of Bonn, Germany.
Seizure. 2017 Oct;51:114-120. doi: 10.1016/j.seizure.2017.08.006. Epub 2017 Aug 18.
We here evaluated (1) the differential characteristics of status epilepticus (SE) in older (≥60 years) compared to younger adults (18-59 years). In particular, we were interested in (2) the proportion and characteristics of new onset SE in patients with no history of epilepsy (NOSE) in older compared to younger adults, and (3) predictive parameters for clinical outcome in older subjects with NOSE.
We performed a monocentric retrospective analysis of all adult patients (≥18years) admitted with SE to our tertiary care centre over a period of 10 years (2006-2015) to evaluate clinical characteristics and short-time outcome at discharge.
One-hundred-thirty-five patients with SE were included in the study. Mean age at onset was 64 years (range 21-90), eighty-seven of the patients (64%) were older than 60 years. In 76 patients (56%), SE occurred as NOSE, sixty-seven percent of them were aged ≥60 years. There was no age-dependent predominance for NOSE. NOSE was not a relevant outcome predictor, especially regarding age-related subgroups. Older patients with NOSE had less frequently general tonic clonic SE (GTCSE; p=0.001) and were more often female (p=0.01). Regarding outcome parameters and risk factors in older patients with NOSE, unfavourable outcome was associated with infections during in-hospital treatment (0.04), extended stay in ICU (p=0.001), and generally in hospital (p<0.001).
In our cohort, older patients represented the predominant subgroup in patients with SE. Older patients suffered more often from non-convulsive semiology and had a less favourable short-time outcome. NOSE was not a predictive outcome parameter in older patients. Data suggest that avoiding infections should have a priority because higher infection rates were associated with unfavourable outcome.
我们在此评估了(1)老年(≥60 岁)与年轻成人(18-59 岁)癫痫持续状态(SE)的差异特征。特别感兴趣的是(2)在无癫痫病史(NOSE)的老年患者中,新发 SE 的比例和特征与年轻成人相比,以及(3)老年 NOSE 患者的临床预后预测参数。
我们对在 10 年期间(2006-2015 年)因 SE 入住我院三级护理中心的所有成年患者(≥18 岁)进行了单中心回顾性分析,以评估发病时的临床特征和出院时的短期预后。
本研究共纳入 135 例 SE 患者。发病时的平均年龄为 64 岁(范围 21-90),87 例(64%)患者年龄大于 60 岁。在 76 例(56%)患者中,SE 为 NOSE,其中 67%的患者年龄大于 60 岁。NOSE 无年龄依赖性优势。NOSE 不是一个相关的预后预测因素,尤其是在年龄相关亚组中。NOSE 的老年患者较少发生全身性强直-阵挛 SE(GTCSE;p=0.001),更多为女性(p=0.01)。关于老年 NOSE 患者的预后参数和危险因素,住院期间治疗期间感染(0.04)、延长 ICU 入住时间(p=0.001)以及一般住院时间(p<0.001)与不良预后相关。
在我们的队列中,老年患者是 SE 患者的主要亚组。老年患者更常出现非惊厥性半侧体征,短期预后较差。NOSE 不是老年患者的预后预测参数。数据表明,应优先避免感染,因为较高的感染率与不良预后相关。